C7R.CD30.CAR-EBVST cells: Clinical Trials

1 trial of C7R.CD30.CAR-EBVST cells, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1

Follow C7R.CD30.CAR-EBVST cells: new trials by email Literature Review of C7R.CD30.CAR-EBVST cells trials Research Report on C7R.CD30.CAR-EBVST cells

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Constitutive IL7R (C7R) Modified Banked Allogeneic CD30.CAR EBVSTS for CD30-Positive Lymphomas
C7R.CD30.CAR-EBVST cells - CD30-Positive Diffuse Large B-Cell Lymphoma, Anaplastic Large Cell Lymphoma, T Cell and Null Cell Type
Phase 1RecruitingBaylor College of Medicine902025-10-272026-10-02

Conditions studied

Hodgkin Disease (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoma, T-Cell, Peripheral (1)

Sponsors

Baylor College of Medicine (1)

Countries

United States (1)

Top investigators

Helen Heslop, MD (1)  ·  Premal Lulla, MD (1)